Tag: weigh

Categories
Politics

In New Hampshire, Republicans Weigh One other Onerous Proper Candidate

In New Hampshire, Republicans Weigh Another Hard Right Candidate

MANCHESTER, NH — He has said the state’s popular Republican governor is “a Chinese Communist sympathizer,” called for the repeal of the 17th Amendment allowing direct popular election of senators and raised the possibility of abolishing the FBI

The man behind these statements is Don Bolduc, a retired Army general, who leads the Republican field in what should be a competitive race for the New Hampshire Senate seat held by Senator Maggie Hassan, a Democrat.

In one primary after another this year, Republican voters have chosen hard-right candidates who party officials had warned would have trouble winning in November, and Mr. Bolduc could be on course to be the next. Like him, many embraced former President Donald J. Trump’s election denial. “I signed a letter with 120 other generals and admirals saying that Donald Trump won the election and, damn it, I stand by” it, Mr. Bolduc said at a recent debate.

The suddenly fraught midterm landscape for Republicans caused Senator Mitch McConnell, the GOP leader, to complain recently that poor “candidate quality” could cost his party a majority in the Senate that had long seemed the likely result.

In the final competitive primary of the year, scheduled for Sept. 13, Republican officials in New Hampshire are echoing Mr. McConnell. They warn that grass-roots voters are poised to elect another problematic nominee, Mr. Bolduc, and jeopardize a winnable race against a vulnerable Democrat.

This month, Gov. Chris Sununu, a Republican moderate broadly popular in his purple state, said on New Hampshire talk radio that Mr. Bolduc was a “conspiracy theorist-type candidate.” He added: “If he were the nominee, I have no doubt we would have a much harder time trying to win that seat back.”

Mr. Bolduc, who served 10 tours in Afghanistan, held a formidable lead with Republican voters in a poll this month, in large part because he has barnstormed continuously for more than two years, while his rivals joined the race later. The contest was effectively frozen for a year until November, when Mr. Sununu, a top recruiting target of national Republicans, declined to run for Senate, deciding instead to seek a fourth term as governor.

Mr. Bolduc has built a following by offering red meat to the conservative base. But New Hampshire is a politically divided state where Republicans who win statewide traditionally appeal to independents and conservative Democrats. Its four-member congressional delegation is entirely Democratic; State government is firmly in the hands of Republicans.

“We’re not a red state, we’re not a blue state, we’re a weird state,” said Greg Moore, a Republican operative not involved in the Senate primary. He was skeptical that Mr. Bolduc, after targeting only his party’s base, would be able to attract a broader coalition in November.

In a debate on Wednesday outside Manchester, Mr Bolduc denounced the provision in Democrats’ Inflation Reduction Act authorizing Medicare to negotiate lower drug prices, saying, “Anything the government’s involved in, it’s not good, it doesn’t work.”

A rival of Mr. Bolduc’s, Kevin Smith, told him at an earlier debate, “You know, Don, your MO seems to be ‘Fire, ready, aim.'”

Mr. Bolduc, 60, is a compact figure who still sports a military haircut close-cropped on the sides. In the minutes before the debate went live on Newsmax, while other candidates studied their notes, he spontaneously led the audience in the Pledge of Allegiance and in singing “God Bless America.”

A poll this month by the New Hampshire Institute of Politics showed Mr. Bolduc with support from 32 percent of registered Republican voters, well ahead of his closest rival, Chuck Morse, the State Senate president, who was at 16 percent. Others in the poll, including Mr Smith, a former Londonderry town manager, were in the low single digits.

All of the candidates have struggled to raise money and draw voters’ attention — 39 percent of Republicans said in the poll they were still undecided.

That gives Mr. Bolduc’s rivals hope, although time is running out: The primary is just one week after Labor Day, when most voters traditionally tune in.

Ms. Hassan has long been seen as vulnerable. Just 39 percent of voters in the Institute of Politics survey said they deserved to be re-elected.

At the debate outside Manchester, the candidates bashed Ms. Hassan, a former governor, linking her to rising gas prices and expected high prices for home heating oil this winter.

Ms Hassan, in response, defended voting for Democrats’ climate and prescription drug law. “While I’m fighting to get results for New Hampshire, my opponents are out on the campaign trail defending Big Oil and Big Pharma and bragging about their records of opposing a woman’s fundamental freedom,” she said in a statement.

Mr. Trump has made no endorsement in New Hampshire, and he may not make one at all. He snubbed Mr. Bolduc in a 2020 Senate primary, endorsing a rival. Neither Mr Bolduc nor Mr Morse have spoken to Mr Trump lately about the race, according to their campaigns.

Corey Lewandowski, Mr. Trump’s first 2016 campaign manager, who is a New Hampshire resident, has publicly urged his former boss not to back Mr. Bolduc, calling him “not a serious candidate.”

Mr. Bolduc declined to comment for this article. Rick Wiley, a senior adviser to Mr. Bolduc, said the criticisms of him — that he is unelectable, that independents won’t vote for him — were the same ones thrown at Mr. Trump in 2016.

“The electorate wants an outsider, that is resoundingly clear,” Mr. Wiley said. Shrugging off Mr. Sununu’s criticisms, he added: “I expect we’re probably going to be sharing a ballot with the governor. There will be unity on the ticket in November and Republicans up and down the ballot will be successful because of the policies Biden and Maggie Hassan have put in place.”

The biggest primary threat to Mr. Bolduc, and the preferred candidate of much of what remains of the GOP establishment, is Mr. Morse, a low-key, self-made tree nursery owner with a strong Granite State accent, who appears in his TV ads riding a tractor at dawn at his operation in southern New Hampshire.

Despite his prominent role in state government, a poll in April found that 54 percent of Republican voters didn’t know enough about Mr. Morse to have an opinion. Just 2 percent named him as their choice for the nomination. His rise to 16 percent in the latest public poll this month is seen by supporters as a sign of momentum.

Dave Carney, a strategist for Mr Morse, agreed that Mr Bolduc was the current race leader. But he said that Mr. Morse’s superior fund-raising, which allowed him to buy TV ads, was raising his profile, and predicted that he would continue to gain on Mr. Bolduc.

“Sixty-one percent of the voters are willing to replace Hassan,” Mr. Carney said, referring to the share of voters in the Institute of Politics survey who said that it was time to give someone new a chance to be senator or that they were undecided. “We need to nominate somebody who can do that.” He called Mr. Bolduc a “flawed candidate,” adding, “I don’t think there’s any way in hell he could get conservative Democrats or the vast majority of independents to go his way.”

Mr. Morse had $975,000 in his campaign account as of July, compared with Mr. Bolduc, who had just $65,000. Ms. Hassan’s $7.3 million on hand has allowed her to aggressively spend on TV ads all year, including one promoting her work for people with disabilities that features her son who was born with cerebral palsy.

The National Republican Senatorial Committee, which this month slashed its planned spending in three battleground states — Pennsylvania, Arizona and Wisconsin — has kept a commitment to spend $6.5 million on the New Hampshire race after the primary, reflecting its belief in Ms. Hassan’s vulnerability.

With the Senate divided 50-50 between the parties and Democrats optimistic about flipping at least one seat, in Pennsylvania, Republicans need to take down two or more Democratic incumbents to win a majority. Their top targets are in Georgia, Arizona, Nevada and New Hampshire.

At the recent debate, the audience was mostly committed supporters of each of the candidates, with few appearing undecided. Bolduc fans dismissed out of hand Mr. Sununu’s view that their candidate would have a hard time in November.

“Sununu is a globalist clown and is not a Republican,” said Kelley Potenza, a candidate for the state House of Representatives who is from Rochester. “He’s afraid because Don Bolduc is the only candidate that’s not going to be controlled.”

In the audience before the lights went down, Bill Bowen, a recent transplant from California and a Morse supporter, said Mr. Bolduc had reached his ceiling in the polls. He said supporters of Mr Bolduc who ignored doubts about his electability in November were misguided.

“That’s all that matters,” he said, adding, “This is the 51st vote,” referring to a potential Republican majority in the Senate.

Categories
Health

Nations weigh mandates and incentives to drive up vaccination charges.

Nations weigh mandates and incentives to drive up vaccination rates.

The coronavirus pandemic has exposed economic and social upheaval around the world, but Covid-19 vaccines have made the gap even wider: while some poor countries are asking for doses to save their populations, some rich countries are being inundated by gunfire and are missing to customers.

For example, a handful of US states have tried to incentivize more people to be vaccinated. But in Moscow, as Covid hospital admissions spiked this week, city government took a tougher line, ordering vaccinations for many workers in public jobs.

Some other governments have also tried to require vaccines. A province in Pakistan has announced that it will cut salaries for officials who have not been vaccinated starting next month. And the UK, which is seeing an increase attributable to the spread of the Delta variant of the virus, is considering making syringes mandatory for all healthcare workers.

The Moscow Times quoted the city’s mayor, Sergei S. Sobyanin, on Wednesday as saying, “When you go out and come into contact with other people, you are an accomplice in the epidemiological process – a chain in the link that is spreading this dangerous virus . “The mandate he announced focuses on education, entertainment, healthcare and hospitality and will continue until at least 60 percent of employees are vaccinated, the newspaper reported.

In the UK, officials said vaccinating health workers would help stop the virus from spreading in hospitals. Nadhim Zahawi, the UK’s vaccines minister, said there was a precedent for such a requirement. “Of course, surgeons are vaccinated against hepatitis B so we definitely think about it,” he told Sky News last month.

Many universities in the United States now require at least some students and employees to be vaccinated. Earlier this week, the University of California’s system announced that it would make Covid-19 vaccinations mandatory for all faculties, staff and students, including the university’s health care system, this fall.

Federal officials have repeatedly made it clear that most companies with at least 15 employees have the right to require workers to be vaccinated.

But the need for vaccines continues to meet resistance from some.

In 15 American states, not a single college had announced any type of vaccine requirement until last month. Days ago, 178 Houston Methodist Hospital employees who refused to receive a coronavirus injection were suspended. And on Saturday, protesters are expected at the New York State Bar Association offices in Albany, where officials will discuss a report recommending prescribing a coronavirus vaccine for all New Yorkers unless doctors exempt them.

But for the undecided, persuaded, incentives to get the vaccine remain common: there are lotteries in California, college scholarships in New York state, and free drinks in New Jersey.

Categories
Business

Well being Advocate or Huge Brother? Firms Weigh Requiring Vaccines.

Health Advocate or Big Brother? Companies Weigh Requiring Vaccines.

As American companies prepare to bring large numbers of workers back to the office in the coming months, executives face one of their most sensitive decisions related to pandemics: should they require employees to be vaccinated?

Take the case of United Airlines. In January, CEO Scott Kirby announced in a company town hall that he would require all of its 96,000 or so employees to receive coronavirus vaccines as soon as they are widely available.

“I think it’s the right thing,” Kirby said before asking other companies to follow suit.

It’s been four months. No major airline has made a similar promise – and United Airlines is waffling.

“It’s still something we think about, but no final decisions have been made,” said a spokeswoman, Leslie Scott.

For the largest companies in the country, mandatory vaccinations would protect service workers and reduce fear of office workers returning. This includes those who have been vaccinated but may be reluctant to return without knowing if their colleagues did too. And there is an element of the civil service: the herd immunity target has fallen as the pace of vaccinations has slowed.

However, the mandatory vaccination could spell a backlash and possibly even litigation for those who see it as an invasion of privacy and a Big Brother-like move to control the lives of employees.

In surveys, executives show willingness to request vaccinations. In a survey of 1,339 employers conducted by Arizona State University’s College of Health Solutions and funded by the Rockefeller Foundation, 44 percent of US respondents said they wanted to require vaccinations for their companies. In a separate survey of 446 employers conducted by Willis Towers Watson, a risk management company, 23 percent of respondents said they “plan or consider having employees vaccinated before they can return to the job site.”

That discrepancy, said Mara Aspinall, who led the survey in the state of Arizona, may have to do with the timing of the surveys and the pace at which executives are comfortable with the vaccines. The State of Arizona conducted its survey in March, while Willis Towers conducted the survey between February 23 and March 12.

Despite the surveys, few executives have taken the step to prescribe vaccines. It seems that most hope that encouragement, whether powerful or subtle, will be enough.

“While legally in the United States, employers can prescribe vaccines while providing shelter for religious and health reasons. This is much more difficult socially in terms of social acceptance of these decisions,” said Laura Boudreau, professor of public policy at the University from Columbia. “And so the reputational risks for these companies, if they get it wrong, are really high.”

Douglas Brayley, an employment law attorney at global law firm Ropes & Gray, warns clients of the implications of fulfilling a mandate, he said.

“What if 10 percent of your workforce refuses? Are you ready to lay off that 10 percent? “He said he asked customers. “Or what if it was someone at a high level or in a key role, would you be willing to impose consequences? And then sometimes they get more nervous. “

He added, “Anytime they mandate but then implement the consequences unevenly, they run the risk of potentially unlawful, unfair treatment.”

Updated

May 6, 2021, 7:57 p.m. ET

Companies in need of vaccines may also be concerned about side effects or medical issues that an employee claims were caused by the vaccine.

“You could be held liable for any kind of adverse effects that might occur a year or two later,” said Karl Minges, chairman of health administration and policy at the University of New Haven.

Some companies work around the problem and try incentives instead. Amtrak pays employees a regular wage of two hours per shot after proof of vaccination. Darden, which owns Olive Garden and other restaurants, told staff that they would offer hourly staff two hours of wages for every dose they received, stressing that it would not make mandatory doses mandatory. Target is offering a $ 5 voucher to all customers and employees who receive their vaccination at a CVS at the Target location.

In the United States, the need for vaccines for participation in public life is nothing new. The Supreme Court ruled about a century ago that states could require vaccinations for children attending public schools. And universities like Rutgers have introduced mandatory Covid-19 vaccinations.

However, the pandemic brings with it a number of complications that companies typically prefer to avoid, including personal life, religious preferences, and employee medical history, such as: For example, if an employee is pregnant, breastfeeding, or immunocompromised, information they may not want to reveal.

Large union groups such as the AFL-CIO have also not aggressively promoted the issue. They face dueling forces – on the one hand they stand up for the rights of the individual employees and on the other hand protect each other. The unions have also spoken out in favor of stricter safety measures in the workplace. These efforts could be hampered by companies’ reasoning that compulsory vaccinations reduce the need for such shelters. For example, the return to work protocols negotiated between the Alliance of Motion Picture & Television Producers and Hollywood’s unions do not include mandatory vaccinations.

“There will be some people who have valid reasons for not getting the vaccine or wanting to talk about it,” said Carrie Altieri, who works in communications for the IBM People and Culture business. “It’s not an easy problem at this point.” IBM is working with New York State on a digital passport that links a person’s vaccination records to an app to display businesses, such as venues, that may require vaccination. However, no vaccinations are required for employees.

For some businesses, such as restaurants, that are already struggling to recruit, the vaccination requirement could make it even more difficult to hire. And there are questions of logistics and execution. How can companies confirm the veracity of those who say they have been vaccinated?

Businesses may need to hire additional staff, possibly with medical training, to perform tasks that could cost businesses – especially small ones – high costs.

Vivint, a Utah-based home security company with 10,000 employees, began offering vaccines at its on-site clinic this week after the state approved the company to distribute 100 shots a week to its employees. It paid $ 3,000 for the necessary medical freezer.

“We don’t require employees to be vaccinated, but we encourage them very much,” said Starr Fowler, senior vice president of human resources. “For many of our employees, especially younger ones, the easier we make it for them, the more likely they will do it.”

Others experiment with the division of their labor force. Salesforce is rolling out a policy in certain US offices, including the Salesforce Tower in San Francisco, where up to 100 fully vaccinated employees can volunteer to work on specific floors. The New York Stock Exchange issued a memo to trading firms saying they could increase their staff on the floor, provided all staff were vaccinated.

The Equal Employment Opportunity Commission issued guidelines in December stating that employers were actually legally allowed to require workers to be vaccinated before returning to work. However, there is still a risk of litigation.

“Concerning the possibility of litigation seems to me a perfectly legitimate concern,” said Eric Feldman, a law professor at the University of Pennsylvania. He added, “It seems to me that employers will be in a pretty strong position legally – but that doesn’t mean they won’t be sued.”

According to the National Conference of State Legislatures, legislation has been proposed in at least 25 states that would limit the ability to require vaccines for students, employees, or the public in general. Some of these restrictions only affect vaccines that, like those for Covid-19, have not yet been fully approved by the Food and Drug Administration. (The coronavirus vaccines have been approved for emergencies with reservations.)

Pfizer is expected to file for full approval of its Covid-19 vaccine soon. Others are likely to follow.

Jamie Dimon, the executive director of JPMorgan Chase, spoke at a conference in the Wall Street Journal this week on “legal issues with obtaining vaccines” when asked if he would like to get workers back into the office. A spokesman for the bank, which plans to open its offices on May 17 on a voluntary basis, said it had strongly recommended vaccines for employees – apart from religious or health restrictions – but would not need them. A Goldman Sachs spokeswoman, who did not lead the staff one way or another, declined to comment.

One possible avenue for companies looking for a middle ground is to only award the shots to new hires. Even so, there is a fine line between encouraging and requiring the gunshot – which sometimes leads to conflicting messages to employees.

Investment bank Jefferies sent a memo to employees in early February stating, “Vaccination verification is required to access the office.” A follow-up memo was issued on February 24th. “We didn’t want it to sound like we were prescribing vaccines,” it said.

Coverage was contributed by Rebecca Robbins, Sapna Maheshwari, Kellen Browning, Niraj Chokshi and Eshe Nelson.

Categories
Health

Which Covid Vaccine Ought to You Get? Specialists Weigh the Impact Towards Extreme Illness

Which Covid Vaccine Should You Get? Experts Weigh the Effect Against Severe Disease

At first glance, the results reported on Friday of the long-awaited study of Johnson & Johnson’s coronavirus vaccine may have been disappointing. Overall effectiveness – the ability to prevent moderate and severe illnesses – was reported at 72 percent in the United States, 66 percent in Latin American countries, and 57 percent in South Africa.

These numbers are well below the high bar set by Pfizer-BioNTech and Moderna, the first two emergency vaccines approved in the United States, which had an overall effectiveness of 94 to 95 percent.

Dr. Anthony S. Fauci, the nation’s leading infectious disease expert and now President Biden’s leading medical advisor on the coronavirus pandemic, acknowledged the remarkable difference at a briefing Friday.

“If you woke up and say, ‘Well, go to the left door and you get 94 or 95 percent, go to the right door and you get 72 percent. ‘Which door do you want to go to? ”He asked.

Dr. However, Fauci said the most important measure is the ability to prevent serious illness, which means keeping people out of the hospital and preventing deaths. For Johnson & Johnson, that result was 85 percent in all of the countries it was tested in, including South Africa, where a rapidly spreading variant of the virus had shown some ability to evade vaccines.

More important than preventing “some pain and a sore throat,” said Dr. Fauci, is the defense against serious illnesses, especially in people with underlying diseases and in older adults who are more likely to become seriously ill and die of Covid. 19th

“If you can prevent serious illness in a high percentage of people, it will soothe the stress of human suffering and death in this epidemic that we are seeing it right now,” said Dr. Fauci, “As we know, over the past few weeks our healthcare system has been burdened by the number of people requiring hospitalization and intensive care.”

Dr. Francis Collins, director of the National Institutes of Health, compared the ability to prevent serious illness to the effects of flu vaccinations, which may not always prevent influenza completely, but make it less severe.

“The same seems to be true here, in circumstances where this variant clearly makes it a little harder to get the most forceful response you want,” said Dr. Collins. “But it still looks very good for serious illnesses.”

The Moderna vaccine also showed high 100 percent effectiveness against serious illnesses. The Pfizer BioNTech appeared to be too, but the total number of severe cases in the study was too few to be certain.

However, the researchers caution that trying to compare effectiveness between new and previous studies can be misleading because the virus is developing quickly and the studies have to some extent examined different pathogens.

“You have to realize that Pfizer and Moderna had an advantage,” said Dr. William Schaffner, an infectious disease expert at Vanderbilt University, in an interview. “They did their clinical studies before the variant strains became very clear. Johnson & Johnson not only tested their vaccine against the standard strain, but they also had the variants. “

The best way to stop the spread of mutants and prevent new ones from emerging is to vaccinate as many people as you can as soon as possible, says Dr. Fauci and other researchers. Viruses can’t mutate if they can’t replicate, and they can’t replicate if they can’t get into cells. Keeping them away from people by immunizing them can kill the process.

In addition to the Pfizer BioNTech and Moderna vaccines already in use in the US, three more may soon be available: those made by Novavax, Johnson & Johnson and AstraZeneca. AstraZeneca’s vaccine has already been approved in the UK and other countries.

Globally, the Johnson & Johnson vaccine is expected to play an important role, especially in low- and middle-income countries, as it works after just one shot, is relatively inexpensive, and is easier to store and distribute than Pfizer-BioNTech’s manufactured vaccines and Moderna, as it does not share their strict requirements for freezing and chilling.

People waiting to be vaccinated may wonder if they will be able to choose vaccines and if they should hold out and wait until the one that looks best to them becomes available.

Covid19 vaccinations>

Answers to your vaccine questions

Am I eligible for the Covid vaccine in my state?

Currently more than 150 million people – almost half of the population – can be vaccinated. But each state makes the final decision on who goes first. The country’s 21 million healthcare workers and three million long-term care residents were the first to qualify. In mid-January, federal officials asked all states to open eligibility to anyone over the age of 65 and adults of any age with medical conditions that are at high risk of becoming seriously ill or dying of Covid-19. Adults in the general population are at the end of the line. If federal and state health authorities can remove bottlenecks in the distribution of vaccines, everyone over the age of 16 is eligible as early as spring or early summer. The vaccine has not been approved in children, although studies are ongoing. It can take months before a vaccine is available to anyone under the age of 16. For the latest information on vaccination guidelines in your area, see your state health website

Is the Vaccine Free?

You shouldn’t have to pay anything out of pocket to get the vaccine, despite being asked for insurance information. If you don’t have insurance, you should still get the vaccine for free. Congress passed law this spring banning insurers from applying cost-sharing such as a co-payment or deductible. It consisted of additional safeguards prohibiting pharmacies, doctors, and hospitals from charging patients, including uninsured patients. Even so, health experts fear that patients will end up in loopholes that make them prone to surprise bills. This could be the case for people who are charged a doctor’s visit fee with their vaccine or for Americans who have certain types of health insurance that are not covered by the new regulations. If you received your vaccine from a doctor’s office or emergency clinic, talk to them about possible hidden costs. To make sure you don’t get a surprise invoice, it is best to get your vaccine at a Department of Health vaccination center or local pharmacy as soon as the shots become more widely available.

Can I choose which vaccine to get?How long does the vaccine last? Do I need another next year?

That is to be determined. It is possible that Covid-19 vaccinations will become an annual event just like the flu vaccination. Or the vaccine may last longer than a year. We’ll have to wait and see how durable the protection from the vaccines is. To determine this, researchers will track down vaccinated people to look for “breakthrough cases” – those people who get Covid-19 despite being vaccinated. This is a sign of a weakening of protection and gives researchers an indication of how long the vaccine will last. They will also monitor the levels of antibodies and T cells in the blood of people who have been vaccinated to see if and when a booster shot might be needed. It is conceivable that people might need boosters every few months, once a year, or just every few years. It’s just a matter of waiting for the data.

Does my employer need vaccinations?Where can I find out more?

Dr. Paul Offit, a vaccines expert at Philadelphia Children’s Hospital, told CNN that Pfizer-BioNTech and Moderna vaccines would be his first choice when they were abundant because of their higher overall effectiveness.

But right now there aren’t enough of these vaccines.

If he couldn’t get the Pfizer BioNTech vaccine or the Moderna vaccine, he would do the Johnson & Johnson shot, said Dr. Offit – as long as the data the company will submit to the Food and Drug Administration looks as good as the company reported on Friday.

He said Johnson & Johnson’s Serious Disease Reduction Report was a strong selling point.

“That’s what you want,” said Dr. Offit. “You want to stay out of the hospital and out of the morgue.”

He noted that the company was also investigating a two-shot regimen that could increase its effectiveness.

People taking the Johnson & Johnson vaccine should be able to safely get a Pfizer BioNTech or Moderna vaccine later if a booster shot is needed, he said.

Dr. Schaffner said he had just attended a meeting with other public health experts and they asked each other what they would say to their spouses or partners if they could get the Johnson & Johnson vaccine tomorrow or had to wait three weeks Pfizer- BioNTech’s or Moderna’s.

“We all said, ‘Get it tomorrow,” said Dr. Schaffner. “The virus is bad. You risk another three weeks of exposure instead of receiving protection tomorrow.”

He said the 85 percent effectiveness of Johnson & Johnson against serious illnesses is a little less than that reported by Moderna and Pfizer-BioNTech, “but it’s still damn high.”

It is not yet known whether it is safe to take a different type of vaccine every now and then, said Dr. Schaffner, adding, “We haven’t investigated this.”

Categories
World News

Inventory futures fall as merchants weigh stimulus prospects and surging Covid circumstances

Stock futures fall as traders weigh stimulus prospects and surging Covid cases

Stock futures fell early Tuesday as traders watched negotiations on additional fiscal stimulus as the U.S. coronavirus case number continued to rise.

Dow Jones Industrial Average futures implied an opening loss of around 150 points. S&P 500 futures and Nasdaq 100 futures were also lower.

Tesla shares fell from a record high after the electric vehicle maker announced it was selling up to $ 5 billion worth of shares.

Republican and Democratic leaders said Monday that Congress is trying to extend state funding for another week to try to reach an agreement on the new Covid-19 aid. The news came after a bipartisan group of senators tabled a $ 908 billion stimulus proposal last week.

“The news from DC that talks on fiscal stimulus have resumed is also a positive development (although this might all be hats, not beasts, until a deal actually gets past the president’s desk),” wrote Willie Delwiche, investment strategist at Baird. “These headlines come at a critical time as we remain in a challenging time from both a health and an economic perspective.”

Calls for a new relief bill to be enforced before the end of the year has risen recently as U.S. employment growth continues to slow and the number of Covid-19 cases continues to rise.

According to the Johns Hopkins University, more than 14.8 million coronavirus cases have been confirmed in the United States. The country’s daily infection rate is also at an all-time high, averaging seven days.

This recent surge in Covid-19 cases has prompted several states and cities to introduce stricter social distancing measures. New York Governor Andrew Cuomo said Monday that New York City could lose indoor dining next week, adding that stricter restrictions would be imposed if hospitals reach a critical point.

“You cannot overwhelm the hospital system,” said Cuomo. “Overpowering the hospital system means people die on a stretcher in a hallway.”

The spike in Covid infections combined with uncertainty about additional tax subsidies kept the Dow and S&P 500 off record levels on Monday. The Dow slipped nearly 150 points, or 0.5%. The S&P 500 retreated 0.2%. However, the Nasdaq Composite rose 0.5% to a new record as traders sold value stocks in favor of soaring growth names.

The iShares Russell 1000 Value ETF (IWD) was down 0.6%. Its growth counterpart, the iShares Russell 1000 Growth ETF (IMF), rose 0.4%.

Subscribe to CNBC PRO for exclusive insights and analysis as well as live business day programs from around the world.